TOVX Stock Analysis: Buy, Sell, or Hold?
TOVX - Theriva Biologics, Inc.
$0.26
-0.03 (-9.66%)
▼
5d:
-10.08%
30d:
-33.19%
90d:
+41.15%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When TOVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TOVX is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TOVX is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TOVX is currently trading at $0.26, which is considered oversold relative to its 30-day fair value range of $0.28 to $0.36.
Technical Outlook: Technically, TOVX is in a strong uptrend. The price is currently testing key support at $0.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.50 (+879.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TOVX is in a strong uptrend. The price is currently testing key support at $0.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.50 (+879.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.28 -
$0.36
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.7%)
- BULLISH: Trading 879.6% below Wall St target ($2.50)
- WARNING: Recommendation downgraded due to -10.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.28 -
$0.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.26
Resistance Level
$0.32
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.28
Wall Street Target
$2.50
(+879.6%)
Share & Embed Analysis
Last updated: June 06, 2026 5:29 AM ET
Data refreshes hourly during market hours. Next update: 6:29 AM
Data refreshes hourly during market hours. Next update: 6:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TOVX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$446 | 60 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1023 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$82 | 59 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 53 HOLD |